IMDX
Insight Molecular Diagnostics
IMDX
IMDX
86 hedge funds and large institutions have $81.2M invested in Insight Molecular Diagnostics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 31 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $120M → $81.2M (-$38.7M)
45% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 31
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
86
Holding in Top 10
1
Calls
$255K
Puts
$22K
Top Buyers
| 1 | +$539K | |
| 2 | +$306K | |
| 3 | +$135K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$106K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.1K |
Top Sellers
| 1 | -$818K | |
| 2 | -$379K | |
| 3 | -$352K | |
| 4 |
Millennium Management
New York
|
-$306K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$160K |